(Q84469208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Arresting type 1 diabetes after diagnosis: GAD is not enough (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Chantal Mathieu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

27 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9788

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

291-292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Use of nonobese diabetic mice to understand human type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960978-1

7 January 2021

10.1016/S0140-6736(11)60978-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21715000%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference